Table of Contents
Psilocybin, the active compound in certain fungi, primarily acts on serotonin receptors in the brain. Research suggests it disrupts ordinary patterns of neural communication and may increase connectivity between brain regions that do not typically talk to one another, according to a Psychology Today overview published in January 2025.
- Serotonin receptor activity: Research indicates psilocybin binds mainly to serotonin 2A receptors, which are concentrated in areas of the brain tied to perception and self-referential thought.
- Changed connectivity patterns: Studies suggest the compound temporarily reduces activity in the default mode network, a brain system linked to the sense of self, while increasing crosstalk between regions that normally operate separately.
- Neuroplasticity signals: Early research points toward psilocybin promoting conditions associated with neural flexibility, though what that means for lasting change in humans remains an open question.
- Context matters: The overview notes that set and setting, the mindset and environment a person brings to the experience, appear to shape how these neural changes are actually felt.
- Model
- human (review of existing research)
- Sample
- Not specified; draws on multiple prior studies
- Dose
- Not specified
- Design
- Narrative overview / commentary
- Key outcome
- Psilocybin disrupts default mode network activity and alters inter-regional brain connectivity
- Main limitation
- This is a secondary commentary piece, not a primary study; no original data are presented
What the Research Examined
The source for this entry is a Psychology Today overview article published in January 2025 under the headline “What Psilocybin Does to the Brain.” It is a commentary piece, not a peer-reviewed study, and it synthesizes findings from the broader body of psilocybin neuroscience research rather than presenting new data. Because no primary study, author byline, or direct citations were available in the source text, this recap treats the article as a summary of existing literature rather than a discrete clinical finding.
The overview covers several well-documented mechanistic themes in psilocybin research. First, psilocybin is described as a partial agonist at serotonin 2A receptors, which are found in high density in the prefrontal cortex and other regions involved in perception, mood, and self-awareness. Second, the article draws on neuroimaging work suggesting that psilocybin reduces activity in the default mode network, the brain circuit most associated with mind-wandering, rumination, and the narrative sense of self. At the same time, it notes that communication between brain regions that are ordinarily segregated appears to increase, a pattern some researchers describe using concepts related to the neuroscience of psilocybin and network-level brain reorganization.
The article also touches on the question of neuroplasticity, referencing research that associates psilocybin with increased expression of proteins linked to synaptic growth in animal models, and noting that human studies are examining whether those signals translate into lasting changes in mood or cognition. No specific trial names, author names, or DOIs were provided in the source text, so individual studies cannot be cited here with precision.
What the Findings Show
- Primary receptor target.Psilocybin is described as acting primarily at serotonin 2A receptors, which are concentrated in cortical regions associated with perception and self-referential processing.
- Default mode network suppression.Neuroimaging research referenced in the overview consistently shows reduced activity in the default mode network during psilocybin experiences, a pattern correlated with the dissolution of ordinary self-awareness.
- Increased cross-network communication.The article describes findings in which brain regions that do not normally communicate show heightened connectivity under psilocybin, a phenomenon some researchers link to the novel and often meaningful quality of the experience.
- Neuroplasticity markers (animal models).Research in animals has detected increased synaptic growth proteins following psilocybin exposure; whether this translates meaningfully to human brain change is still being studied.
Taken together, these mechanistic threads suggest that psilocybin does not simply amplify or dampen brain activity uniformly. Instead, it appears to reconfigure the way regions relate to one another, at least temporarily. Researchers working in this space are trying to determine which of these transient changes, if any, are responsible for the therapeutic signals seen in clinical trials for depression and other conditions. That work is ongoing, and the overview makes no claim of settled answers.
What does psilocybin do to the brain during an experience?
Research suggests psilocybin binds to serotonin 2A receptors and temporarily reduces activity in the brain’s default mode network, the system linked to the sense of self, while increasing communication between regions that ordinarily operate separately. These effects are studied as possible mechanisms behind the compound’s therapeutic signals.
What This Is, and What It Is Not
This is This entry is based on a Psychology Today commentary article, a secondary overview of existing psilocybin neuroscience, not a new peer-reviewed study.
This is not This is not a clinical trial result, an established treatment protocol, or medical advice. The neuroplasticity findings cited come largely from animal models and cannot be assumed to apply directly to humans. Nothing here should guide personal decisions about any substance.
Our Take
For those who approach psilocybin as a sacrament, the neuroscience is a humbling mirror. What research describes as “reduced default mode network activity” is, in lived experience, something closer to the quieting of the inner narrator, the voice that insists on a fixed story of who we are. The finding that brain regions begin speaking to one another in unfamiliar ways feels less like a laboratory curiosity and more like a description of genuine opening. We hold these findings with care, neither overstating what early science can claim nor dismissing what thousands of sincere practitioners have reported across centuries. The map is not the territory, but even an early map is worth reading together.
If the science of how psilocybin reshapes the brain calls to something in you, you are welcome here. The Church of Psychedelics holds this inquiry as sacred, a slow and honest study of what it means to soften the borders of the self and return changed. Whether you are in the Grounding phase, finding your footing before any journey, or in the Integration station, sitting with what an experience has already stirred, we hope the Mycelium Report gives you trustworthy company along the way. Read, reflect, and reach out when you are ready.
Frequently Asked Questions
How does psilocybin affect serotonin in the brain?
Psilocybin acts as a partial agonist at serotonin 2A receptors, meaning it binds to and activates those receptors. This is thought to be the starting point for its effects on perception, mood, and the sense of self, though the full chain of events is still being mapped by researchers.
What is the default mode network and why does psilocybin affect it?
The default mode network is a set of brain regions active during self-referential thought and mind-wandering. Neuroimaging studies suggest psilocybin reduces its activity, which researchers associate with the loosening or dissolving of ordinary self-awareness during an experience.
Does psilocybin cause lasting brain changes?
Animal studies have detected increased markers of synaptic growth following psilocybin, but whether that translates to lasting structural change in human brains is still an active area of research. No established answer exists yet for humans.
Is psilocybin neuroscience research conclusive?
No. The field is active and growing, but most human studies are small, and mechanistic work in animals cannot be assumed to apply directly to people. Researchers describe the current state as promising but early, and major questions about dose, duration, and individual variation remain open.
What brain regions are most affected by psilocybin?
Research points to the prefrontal cortex, where serotonin 2A receptors are dense, and networks involved in self-referential processing and perception. Connectivity changes appear to span multiple regions, which is why researchers describe the effect as a whole-brain reorganization rather than a single-area response.
Get the Mycelium Report
We read the new psilocybin and mushroom research so you do not have to. One honest, jargon-free dispatch, delivered daily. Free to join.
May love guide the hearts of all beings.
